Mediterranean Longevity Diet and Fasting Mimicking Diet in Adolescents With Overweight or Obesity
Key facts
- Who runs it
- Fondazione Valter Longo
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 330 people, planned
- Started
- 3 Nov 2026
- Expected to end
- 30 Nov 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- MLD
- FMD
- Record updated
- 16 November 2026
Who can take part
- Age
- 14 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adolescents (14-18 years of age) with overweight/obesity defined by WHO BMI criteria: Overweight: >+1SD (equivalent to BMI 25 kg/m2 at 19 years) Obesity: >+2SD (equivalent to BMI 30 kg/m2 at 19 years)
Who cannot take part
- individuals with a family member already included in the study; Individuals with severe obesity (WHO BMI > 3 SD equivalent to BMI 35kg/m2 at 19 years); Individual with BMI > 25 kg/m2 but with high percentage of muscle mass and less than 25% of fat mass for male subjects and less than 30% of fat mass for female subjects; individuals who are allergic to tree nuts (macadamia, cashew, almond, pecan), soy, oats, sesame, or celery/celeriac; Pregnant or possibly pregnant females; No evidence of pubertal delay requiring medical evaluation; pharmacological treatments known to interfere with the study treatment; all concomitant medications (including, but not limited to, levothyroxine, asthma medications, etc.) will be evaluated by the study's responsible pediatrician; use of hypoglycemic agents; No history of recurrent syncope or unexplained hypotensive episodes; Diagnosis of a condition listed among the exclusion criteria
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 14 and 18 years old?
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Overweight and obesity are increasingly common in adolescents. Italy, and in particular the Campania region, has one of the highest rates of excess weight in children and adolescents in Europe. Dietary approaches that are effective, safe and realistic for teenagers are needed.
Read full original descriptionShow less
This randomized controlled trial will compare two dietary programs with usual diet in adolescents aged 14 to 18 years with overweight or obesity. The study will test whether the Mediterranean Longevity Diet (MLD) and the Fasting Mimicking Diet (FMD) reduce body mass index (BMI) z-score more than continuing the usual diet, while preserving lean mass and normal growth.
The MLD is based on the traditional Mediterranean diet and adapted to the needs of adolescents. It is rich in vegetables, legumes, whole grains, fish, nuts and olive oil, with limited starchy and sugary foods, limited red meat, poultry, eggs and dairy, a moderate protein intake, and all food eaten within a 12-hour window each day. The FMD is a plant-based, low-calorie 5-day meal program that provides vitamins, minerals and essential fatty acids. It is repeated every 3 months, with the usual diet followed between cycles.
A total of 330 adolescents will be randomly assigned in equal numbers (110 per group) to one of three groups: (1) continuing the usual diet and lifestyle (control group), (2) the MLD for 12 months, or (3) the FMD, one 5-day cycle every 3 months, for 12 months. Participants in the control group may choose to follow the MLD or the FMD for 6 months after the first 6 months of the study.
Participants will attend three clinic visits (start of the study, 6 months and 12 months) and will be contacted every month by a nutritionist. At the visits, the research team will measure height, weight, body circumferences, blood pressure and body composition (bioelectrical impedance analysis), collect fasting blood samples and administer questionnaires on diet, lifestyle and sleep. Optional assessments include liver stiffness measurement (FibroScan), pubertal stage assessment, sleep monitoring with a wearable ring, and psychological support sessions.
The main outcome is the change in BMI z-score. Other outcomes include changes in fat mass, lean mass, waist circumference, blood pressure, blood lipids, glucose, HbA1c, insulin resistance, inflammation markers, liver fat index, sleep and diet quality. Safety is closely monitored, with rules for stopping the diet in case of rapid weight loss, fainting, low blood glucose, abnormal blood salts, or signs of eating disorders.
The study is conducted at the Evangelical Hospital Betania in Naples, Italy, in collaboration with the Valter Longo Foundation (Milan) and other clinical centers in Campania.
The 3 groups in the trial
- ControlloNo study treatment, for comparison
This trial uses a control group to provide robust evidence of the effects of nutritional interventions on the primary and secondary endpoints. Subjects in the control group (arm 1) will be asked to make no changes in dietary programs, exercise programs and nutritional supplements during the first 6 months of the study and before being offered to begin MLD or FMD. The expectation is that subjects will maintain their current weight and not engage in behaviours intended to produce weight loss.
- MLDExisting treatment, for comparison
Adolescents follow a Mediterranean Longevity Diet for 12 months, based on the traditional Mediterranean diet and adapted to adolescents: protein intake of 0.9 g/kg of ideal body weight (half plant-based, half from fish and limited animal sources), predominantly unsaturated fats, complex carbohydrates from vegetables, whole grains and legumes with limited starchy and sugary foods, 1-3 servings of fruit and 30 g of nuts per day, and all food eaten within a 12-hour daily window. Portions are individualized and no food group is eliminated. Participants receive written instructions and monthly nutritionist follow-up.
- FMDTreatment being tested
Adolescents follow their usual diet, except for a 5-day Fasting Mimicking Diet cycle at baseline and then every 3 months for 12 months (up to 5 cycles). The FMD is a plant-based, low-calorie program (about 1000 kcal on day 1 and about 700 kcal on days 2-5) that provides vitamins, minerals and essential fatty acids, delivered in individually boxed daily kits. Participants receive urinary ketone strips for adherence monitoring, a safety call during the first cycle, and monthly nutritionist follow-up.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of the Effects of Periodic Cycles of the Fasting-mimicking Diet or Recommendations for a Continuous Mediterranean Longevity Diet on Body Composition and Health Markers in Adolescents: a Randomized Controlled Trial
- Criteria questions
- Built from NCT07938268, who can take part
- Record updated
- 16 November 2026